From: Dosage balance acts as a time-dependent selective barrier to subfunctionalization
Parameters and Variables | Symbol | Realistic range based on empirical data | Range used in provided figures |
---|---|---|---|
Poisson rate of nucleotide mutations that interfere with transcription binding | ub | 1.0 × 10–8–2.5 × 10–8 nucleotide mutations per generation [70] | 2.5 × 10–8 nucleotide mutations per generation |
Poisson rate of nucleotide mutations that interfere with production of a functional peptide sequence | uh | 1.0 × 10–8–2.5 × 10–8 nucleotide mutations per generation [70] | 2.5 × 10–8 nucleotide mutations per generation |
Length of coding region | lc | 5.0 × 104 nucleotides [71] | 5.0 × 104 nucleotides |
Length of enhancer | lr | 50Â bp to 1.5 kbp [72] | 775 nucleotides |
Subfunctionalization-Only Model poisson rate at which null mutations fix in the coding regions [59] | uc | – | Equation 9, loss of function mutations per generation |
Subfunctionalization-Only Model poisson rate at which null mutations are fixed in each of the z mutable regulatory regions for each gene [59] | ur | – | Equation 10, loss of function mutations per generation |
Number of regulatory regions/domains (promoters/enhancers/silencers) | z |  < 20 regulatory regions | 4 regulatory regions |
Effective population size | Ne | 1.4 × 104 individuals | 1 × 102–1.4 × 106 individuals |
Time in generations since duplication event | t | 5.0 × 103–1.4 × 104generations | 5.0 × 103–1.0 × 104generations |
Equilibrium constant | Keq | 1.0 × 104–1.0 × 1012 mol/mL | |
Scalar on the relationship between the number of hydrophobic patches per cell and the corresponding fitness penalty | w | – | 1.0 |
Heterodimer of interest | AB | – | Equation 1 |
Gene that codes for subunit A in heterodimer AB | GA | – | – |
Gene that codes for subunit B in heterodimer AB | GB | – | – |
Subunit of heterodimer of interest, gene product of GA | A | – | Equation 1 |
Subunit of heterodimer of interest, gene product of GB | B | – | Equation 1 |
Concentration of the heterodimer of interest that is in its bound form | [AB] | – |  |
Total concentration of subunit A, likely to be estimated by transcription data | [A]total | 1 × 10–6–1 × 10–10 mol/mL | 2.5 × 10–6 mol/mL |
Total concentration of subunit B, gene product of GB, likely to be estimated by transcription data | [B]total | 1 × 10–6–1 × 10–10 mol/mL | 2.5 × 10–6 mol/mL |
Concentration of subunit A in the unbound form | [A]free | – | Equation 3, in mol/mL |
Concentration of subunit B in the unbound form | [B]free | – | Equation 4, in mol/mL |
Concentration of exposed hydrophobic patches | [hp] | – | Equation 2, in mol/mL |
Current state | i | – | – |
Next possible state | j | – | – |
Fitness of state | f | – | Equation 6 |
Fitness of current state | fi | 1.0 | Equation 7 |
Fitness of next possible state | fj | – | Equation 7 |
Probability of fixation of mutation | g | – | |
Subfunctionalization, an absorbing state | S | – | |
Pseudogenization/nonfunctionalization, an absorbing state | Y | – |